Oesophageal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with a specific type of oesophageal cancer (either squamous cell carcinoma or adenocarcinoma) or cancer at the junction of the oesophagus and stomach, confirmed by a tissue test
- You are due to have, or have recently had, a combination of chemotherapy and radiotherapy treatment (following a specific programme called CROSS) before surgery to remove the cancer
- You are well enough to have surgery
- You are 18 years old or older
- You are willing and able to give written consent to take part
Who may not be able to join:
- Your cancer did not show up clearly on a specific type of scan called a PET-CT scan, which uses a special sugar-based dye to highlight tumours (confirm with trial site)
- Your initial treatment was a procedure to remove the cancer through an endoscope (a small camera inserted into the body)
- You have had, or are planned to have, chemotherapy and radiotherapy as your main and final treatment (rather than as preparation for surgery)
- You have difficulty with language, memory problems, or a condition affecting your mental state that would prevent you from fully understanding and agreeing to take part in the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Bas Wijnhoven, Dr., Erasmus Medical Center
Phone: +31107041223
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Safety of active surveillance (including delayed surgery), measured by the number of patients with adverse events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.